Serodiagnosis of leishmaniasis

Critical Reviews in Microbiology

Volumn 21, Issue 2, 1995, Pages 123-152

  Kar, Kalipada ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

Author keywords

Circulating antigen; Counter current immunoelectrophoresis; Cutaneous leishmaniasis; Diffuse cutaneous leishmaniasis; Direct agglutination test; Dot ELISA; Enzyme linked immunosorbent assay; Gel diffusion test; Immunoelectrophoresis; Indirect fluorescence antibody test; Kala azar; Leishmania; Leishmaniasis; Leishmanin skin test; Monoclonal antibodies; Mucocutaneous leishmaniasis; Post kala azar dermal leishmaniasis; Radioimmunoassay; Serodiagnosis of leishmaniasis; Visceral leishmaniasis

Indexed keywords

ACID PHOSPHATASE; CONCANAVALIN A; LIPOPHOSPHOGLYCAN; LIPOPOLYSACCHARIDE; MONOCLONAL ANTIBODY; PARASITE ANTIGEN; PROTOZOAL PROTEIN; PROTOZOON ANTIBODY;

AGGLUTINATION TEST; AMASTIGOTE; ANTIGEN ANTIBODY COMPLEX; CELLULAR IMMUNITY; COMPLEMENT FIXATION TEST; COUNTER IMMUNOELECTROPHORESIS; CROSS REACTION; DELAYED HYPERSENSITIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMORAL IMMUNITY; IMMUNOELECTROPHORESIS; IMMUNOFLUORESCENCE TEST; LEISHMANIA; LEISHMANIASIS; PRIORITY JOURNAL; RADIOIMMUNOASSAY; REVIEW; SERODIAGNOSIS; SKIN TEST;

ANIMAL; ANTIBODIES, PROTOZOAN; ANTIGEN-ANTIBODY COMPLEX; ANTIGENS, PROTOZOAN; DIAGNOSIS, DIFFERENTIAL; HUMAN; IMMUNITY, CELLULAR; LEISHMANIA; LEISHMANIASIS; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS;

EID: 0029012223     PISSN: 1040841X     EISSN: None     Source Type: Journal    
DOI: 10.3109/10408419509113537     Document Type: Article

References (194)

1. The Leishmaniasis
2. Leishmania infection: surface and immunity
3. Experimental leishmaniasis: role of trans-aconitic acid in combined chemotherapy
4. Leishmaniasis
5. Diagnosis
6. A galactosyl (1–3) man-nose epitope on phospholipid of Leishmania mexicana and Leishmania braziliensis is recognized by trypanosomatid infected human sera
7. Persistence of elevated levels of galactosyl (1–3) galactose antibodies in sera from cured visceral leishmaniasis patients
8. Serological activity against galactosyl (1–3) galactosidose in sera from patients with several kinetoplastida infections
9. Serological investigation on Indian kala-azar
10. T-cell and cytokine responses in leishmaniasis
11. Factors in host-parasite interactions and immunological upresponsive-ness in leishmaniasis
12. Kala-azar with disseminated dermal leishmaniasis
13. Contribution de la connaissance des antigens de Leishmania a I'immunologic des trypanosomatides
14. Leishmaniasis: immunity, immunopathology and immunodiagnosis
15. Krezveaklionen in der Immunodiagnostik der Chagaskrankheit und der kala-azar unter Einbeziehung von serum Tuberkuloser und Leproser, Zentralbl. Bakteriol Parasitenkd
16. Identification of specific and cross-reactive antigens of Leishmania donovani chagasi by human infection sera
17. Antigenic cross-reactivity between Mycobacteria bovis (BCG) and Leishmania donovani
18. Culture de parasite du bouton d'Orient
19. The cultivation of Trypanosoma brucei. A preliminary note
20. The in vitro cultivation of members of the Leishmania braziliensis complex
21. The cultivation of Trypanosoma cruzi in dialysate medium
22. Observation on the in vitro cultivation of Leishmania braziliensis
23. Comparison of microscopy and cultivation in the detection of Leishmania donovani from splenic aspirates
24. A simple diphasic medium lacking whole blood for culturing Leishmania spp
25. Cultivation of Leishmania: comparison of different media for promastigote cultivation
26. Leishmania donovani: a chemically defined medium suitable for cultivation and cloning of promastigotes and transformation of amastigotes to promastigotes
27. Visceral leishmaniasis: difficult diagnosis and unusual causative agent
28. The diagnosis and management of leishmaniasis
29. Visceral leishmaniasis in Sudan: comparative parasitological methods of diagnosis
30. Epidemiological survey of leishmaniasis using skin test and ELISA in Equador
31. Development of kala-azar in man after incoulation with a Leishmania from a Kenya sandfly
32. Leishmania donovani donovani parasitemia in Kenyan visceral leishmaniasis
33. A new serum test for kala-azar
34. Identification of Leishmania donovani isolate from Chinese different VL foci by kDNA hybridization with biotin-kDNA probe
35. Rapid and sensitive detection of Leishmania kinetoplast DNA from spleen and blood samples of kala-azar patients
36. Presence of an easily precipitable anticomplementary globulin-like substance in human serum and its importance in the diagnosis of kala-azar
37. A simple method for estimating quantitative difference in globulin precipitation test in kala-azar
38. A preliminary note on the action of antimony compounds on the blood serum. A new serum test for kala-azar
39. Possible role of B-cell mitogen in hypergammaglobulinemia in malaria and trypanosomiasis
40. Fluorescent antibody test for the serodiagnosis of visceral leishmaniasis
41. Immunoenzymatic assay (ELISA) in mucocutaneous leishmaniasis, able to distinguish between anti-trypanosome and anti-leishmania antibodies
42. Immunofluorescent antibody test in American visceral leishmaniasis: sensitivity and specificity of different morphological forms of two Leishmania species
43. A simple and economical direct agglutination test for serodiagnosis and seroepidemiological studies of visceral leishmaniasis
44. Serodiagnostic assay for visceral leishmaniasis employing monoclonal antibodies
45. De fixaca do complemento na leishmaniose tegumentar
46. Sur la preparation du antigene stable pour la reaction de fixatio du complement dans leishmaniases
47. A complement fixation test for kala-azar
48. A complement fixation test for visceral leishmaniasis using homologous parasite antigen. I
49. Complement fixation test for visceral leishmaniasis with Mycobacterium tuberculosis antigens
50. La reazione di fissazione del complemento con antigen da B.C.G. nella leishmaniosi viscerale
51. Preparation of purified antigen from Kedrowesky's bacillus for complement fixation test for kala-azar
52. Complement fixation and intradermal skin test with partially purified “proteic” and “polysaccharidic” antigens from Leishmania donovani
53. Serological reactions in kala-azar: complement-fixation, false Wassermann reaction, and high anti-complementary titre
54. Further studies on complement fixation in kala-azar with a specific antigen as an aid to diagnosis
55. Studies on Mediterranean leishmaniasis. I. An outbreak of visceral leishmaniasis in northern Italy
56. Test dell' emoagglutinazione condizionata per la recerca della agglutinin anti
57. Studies in Mediterranean leishmaniasis. V. A. Preliminary epidemiological survey of human leishmaniasis in Tuscany
58. Studies on the immunology and serology of leishmaniasis V. The use of particles as vehicles in passive agglutination tests
59. Passive haemagglutination in leishmaniasis
60. Leishmaniasis
61. On the methods for evaluation of the degree of antigenic relationship of different strains of Leishmania
62. Leishmania
63. Serological profiles on Indian post kala-azar dermal leishmaniasis
64. The present state of leishmaniasis in Iraq
65. Coagglutination and passive haemagglutination in the detection of an excreted immunologically active substance from Leishmania
66. Field techniques in the diagnosis of kala-azar
67. Indirect haemagglutination test for Chagas' disease with a simple method for survey work
68. Immunodiagnosis of kala-azar
69. A direct agglutination test for leishmaniasis
70. A comparison of the direct agglutination test and ELISA in the serodiagnosis of leishmaniasis in the Sudan
71. A direct agglutination test discriminative towards Chagas' disease for the diagnosis of visceral leishmaniasis in Brazil: preliminary results
72. Evaluation of a newly developed direct agglutination test (DAT) for serodiagnosis and seroepidemiological studies of visceral leishmaniasis: comparison with IFAT and ELISA
73. Evaluation of direct agglutination test (DAT) and ELISA for serodiagnosis of visceral leishmaniasis in India
74. Positive response to sodium antimony gluconate administration in visceral leishmaniasis seropositive patients
75. Expression of the major surface glycoprotein of Leishmania donovani chagasi in virulent and attenuated promastigotes
76. Phosphomo-noesterases of Leishmania mexicana mexicana and otfier flagellates
77. Acid phosphatase activity of virulent and avirulent clones of Leishmania donovani promastigotes
78. The generation of infective stage Leishmania triopica promastigotes is associated with the cell surface expression and release of a developmentally regulated glycolipid
79. Post kala-azar dermal leishmaniasis in the absence of active visceral leishmaniasis
80. The value of a DAT test in the diagnosis of cutaneous and visceral leishmaniasis in Ethiopia
81. Pre and post-treatment antibody levels in visceral leishmaniasis
82. Direct agglutination test for diagnosis and sero-epidemiological survey of kala-azar in the Sudan
83. Immunofluorescence dams les leishmanioses comparison ayee la reaction de fixation du complement
84. The detection of circulating antibodies to kala-azar by means of immunofluo-rescent techniques
85. An easily cultured Crithidia sp. as antigen for immunofluorescence for kala-azar
86. Early serological diagnosis in visceral leishmaniasis using Crithidia sp. as antigen
87. Serodiangosis of American leishmaniasis by indirect fluorescent antibody test
88. Applying the indirect immunofluorescence test in the study of American cutaneous leishmaniasis
89. Diagnostic serologique des leishmanioses par immunofluorescence sur coupes des foies ou de rates de hamsters infestes avec Leish-mania donovani
90. Cross-reactivity in fluorescence tests for Trypanosoma and Leishma-nia antibodies. A single inhibition procedure to ensure specific results
91. Circulating antibodies in cutaneous leishmaniasis, their detection by immunofluorescence
92. Microenzyme linked immunosorbent assay (ELISA) for the serodiagnosis of New World leishmaniasis
93. Axenic cultivation and characterization of Leishmania mexicana amastigote-like forms
94. Leishmania mexicana pifanoi: analysis of the antigenic relationship between promastigotes and amastigotes by gel diffusion, immunoelectrophoresis, and immunoprecipitation
95. Monoclonal antibodies specific for the amastigote stage of Leishmania pifanoi. I. Characterization of Leishmania of antigens associated with stage and species-specific determinants
96. Leishmania mexicana pifanoi: antigenic characterization of promastigote and amastigote stages by solid phase radioimmunoassay
97. Evaluation of serological diagnostic indices for mucocutaneous leishmaniasis, immunofluorescence tests and ELISAs for IgG, IgM and IgA antibodies
98. Diagnostic performance indices for immunofluorescence tests and enzyme immunoassays of leishmaniasis sera from northern and northeastern Brazil
99. Perturbation des reactions serologiques de la leishmaniose chez. les paludeens
100. Micro ELISA techniques in the serodiagnosis of visceral leishmaniasis
101. Detection of circulating antibodies in cutaneous leishmaniasis by enzyme-linked immunosorbent assay (ELISA)
102. Immunofluorescence and counterimmunoelectrophoresis in the diagnosis of kala-azar
103. Comparison of the performance of L. major-like and Leishmania braziliensis braziliensis, an antigen for New World leishmaniasis IgG-immunofluorescence test
104. Fluorescent antibody titers after recovery from visceral leishmaniasis
105. Aminoethyl coumarin acetic acid and fluorescein isothiocyanate in detection of leishmanial antibodies: a comparative study
106. Difuse cutaneous leishmaniasis in Ethopia. II. Treatment. III. Immunological studies. IV. Pathogenesis in DCL
107. Immunity in cutaneous leishmaniasis in the guinea pig
108. Antibody responses in patients with cutaneous leishmaniasis of the Old World
109. The indirect fluorescent antibody test for diagnosis of kala-azar infection in Iraq
110. Leishmaniasis in Brazil. X. Some observations on intradermal reactions to different trypanosomatid antigens of patients suffering from cutaneous and mucocutaneous leishmaniasis
111. Fractions antigeniques communes decelees par immuno-precipitation en gelose, entre Mycobacteria phlei (Mycobacteriaceae) et Leishmania donovani (Trypanosomida)
112. Utilization de methodes immunologiques dans to depistage systematique des reservoirs domestiques et sauvages de la leishmaniose viscerale
113. The immunology and serology of leishmaniasis. IV. Results of Ouchterlony double-diffusion tests
114. Evaluation of different subcellular fractions of Leishmania donovani for immunodiagnosis of visceral leishmaniasis
115. Immunological responses in Indian kala-azar
116. Serodiagnosis of visceral leishmaniasis in an endemic area of the Sudan
117. Leishmaniasis in the Old World
118. Biochemical and immunological characterization of exometabolites from an Indian strain of Leishmania donovani promastigotes grown in a chemically defined medium
119. Immunodiffusion, counterimmuno-electrophoresis and immunofluorescence in diagnosis of Sudan mucosal leishmaniasis
120. Counterimmunoelectrophoresis (CIEP) and ELISA tests in the diagnosis of canine leishmaniasis
121. The role of counter immunoelectrophoresis as a diagnostic tool in kala-azar
122. Enzymoimmunoassay in leishmaniasis
123. Use of purified parasite from Leishmania donovani for the rapid serodiagnosis of visceral leishmaniasis
124. A comparison of enzyme-linked immunosorbent assay and indirect fluorescent antibody test in the serodiagnosis of cutaneous and visceral leishmaniasis in Iran
125. The micro-ELISA sandwich technique for the quantitation of Leishmania donovani soluble antigen
126. Cutaneous South American leishmaniasis: parasitological and serological diagnosis by indirect immunofluorescence (IIF) and enzyme-linked-immunoassay (ELISA): study of 94 cases
127. Serodiagnosis of Sudanese visceral and mucosal leishmaniasis: comparison of ELISA-imuno-fluorescence and indirect haemagglutination
128. ELISA using intact promastigotes for immunodiagnosis of kala-azar
129. Development and application of an ELISA kit containing anti-human gamma chain McAb for rapid diagnosis of leishmaniasis
130. An improved sero-diagnostic procedure for visceral leishmaniasis
131. A dot-immunobinding assay for monoclonal and other antibodies
132. Dot enzyme-linked immunosorbent assay (dot-ELISA): a microtechnique for the rapid diagnosis of visceral leishmaniasis
133. Diagnosis of Indian kala-azar by dot enzyme-linked immunosorbent assay (dot-ELISA)
134. A rapid and simple diagnostic test for active visceral leishmaniasis
135. Direct enzyme-linked immunosorbent assay: a simple immunoassay using Leishmania donovani promastigotes for diagnosis of kala-azar
136. Diangosis of human African trypanosomiasis and visceral leishmaniasis based on the detection of antiparasite enzyme antibodies
137. Leishmania tropica and Leishmania donovani: solid phase radioimmunoassay using leishmanial excreted factor
138. Lipid and lipopolysaccharide-like antigens of Leishmania promastigotes
139. Leishmania major: solid phase radioimmunoassay for antibody detection in human cutaneous leishmaniasis
140. Leishmania major: glycolipid antigens recognized by immune sera
141. IgG antibody reactivity with Trypanosoma cruzi and Leishmania antigens in sera of patients wtih Chagas' disease and leishmaniasis
142. Identification of major antigens of Leishmania donovani using kala-azar sera
143. Serum antibody specificities to Leishmania aethiopica antigens in patients wtih localized and diffuse cutaneous leishmaniasis
144. Analysis of the specificity of human antibodies to antigens of L. b. braziliensis
145. Autoantibody production by patients infected with Leishmania
146. Changes in the antigenic profile of Leishmania parasites following shifts in temperature
147. Parasite antigens recognized by patients wtih cutaneous leishmaniasis
148. Monoclonal antibodies that distinguish between New World Species of Leishmania
149. Monoclonal antibodies that distinguish subspecies of Leishmania braziliensis
150. Stage-specific, strain-specific and cross-reactive antigens of Leishmania species identified by monoclonal antibodies
151. Leishmania tropica: surface antigens of intracellular and flagellar forms
152. Monoclonal antibodies to Leishmania tropica major: specificities and antigen location
153. Monoclonal antibody identical to Leishmania tropica from Sudanese mucosal leishmaniasis
154. Production and characterization of species-specific monoclonal antibodies against Leishmania donovani for serodiagnosis
155. Monoclonal antibodies specific for Leishmania tropica. I. Characerization of antigens associated with stage and species-specific determinants
156. Surface antigen of Leishmania donovani promastigotes
157. 125I-labeling and immunoprecipitation
158. A common major surface antigen on amastigotes and promastigotes of Leishmania species
159. Identification of the promastigote surface protease in seven species of Leishmania
160. Identification of monomeric and oligomeric forms of a major Leishmania infantum antigen by using monoclonal antibodies
161. Cloning of a gene encoding the immunodominant surface antigen of Leishmania donovani
162. Purification and characterization of an 80-kilodalton membrane protein from Leishmania donovani
163. Use of purified parasite proteins from Leishmania donovani membrane proteins recognized by visceral leishmaniasis
164. Species and stage specificity of Leishmania donovani antigens
165. Production of a specific monoclonal antibody for the identification of Leishmania (Leishmania) venezuelensis
166. Cloning of Leishmania donovani genes encoding antigens recognized during human visceral leishmaniasis
167. Specific serodiagnosis of visceral leishmaniasis using a Leishmania donovani antigen identified by expression cloning
168. Isolation and characterization of recombinant antigens from Leishmania aethiopica that react with human antibodies
169. lq. Application to the analysis of the components of in vitro-formed immune complexes and of immune complexes occurring in vivo during leishmaniasis
170. Le kala-azar. Etude clinique et physiopathologique a propos d'um nouveau cas observe en Seuisse
171. Identification of leishmanial antigens in the sera of patients with American visceral leishmaniasis
172. New perspectives on a subclinical form of visceral leishmaniasis
173. Identification of immune complex antigens in sera of Indian kala-azar patients
174. Circulating immune complexes and anti-IgG antibodies in mucocutaneous leishmaniasis
175. Detection of circulating antigen in patients wtih visceral leishmaniasis by monoclonal-enzyme linked immunotransferblot technique (EITB)
176. A study of circulating antigen in VL using monoclonal antibody labelled with peroxidase
177. A skin reaction to extract of Leishmania tropica and Leishmania infantum
178. Cutaneous reaction in leishmaniasis
179. A intradermoreacao de Montenegro nas compoanhas sanitarias contra a leishmaniose
180. The intracutaneous test in cutaneous leishmaniasis
181. Immunodiagnosis of leishmaniasis
182. Serological profiles of Indian post kala-azar dermal leishmaniasis
183. Leishmanin test in post kala-azar dermal leishmaniasis
184. Immunity to Leishmania mexicana following spontaneous recovery from Oriental sore
185. Leishmanin skin test standardization and evaluation of safety, dose, storage and longevity of reaction and sensitization
186. Cutaneous leishmaniasis due to Leishmania (L.) amazonensis in Amazonian Brazil, and the significance of a negative Monetenegro skin test in human infections
187. Selection of a skin test antigen for American visceral leishmaniasis
188. The use of different concentrations of leishmanial antigen in skin testing to evaluate delayed hypersensitivity in American cutaneous leishmaniasis
189. The relationship of Leishmania braziliensis subspecies and immune response to disease expression in New World leishmaniasis
190. An analysis of T cell responsiveness in Indian kala-azar
191. Intradermal leishmanin test serves in an area with mixed infestation with Leishmania tropica, Leishmania donovani and Leishmania infantum
192. Evaluation and characterization of partially purified skin test antigens prepared from Leishmania panamensis promastigotes
193. Evaluation of a total lymphocyte proliferation assay as a diagnostic tool for cutaneous leishmaniasis